Latest News

• 2/2/2011 OGX-427 Used with Prednisone Shows Promising Results for Prostate Cancer Patients
• 2/2/2012 Promising New Therapeutic Targets Bone and Disperses Radiation | Alpharadin may decreases bone metastases and reduce death
• 2/2/2012 Seed Therapy for Prostate Cancer May Zap Fertility
• 2/1/2012WSJ Article Shows Rapid Progress in Prostate Cancer | Research and treatment advances continue to climb
• 2/1/2012 Researchers’ Work in Prostate Cancer and Exercise Advances | June Chan focuses on early-stage disease
• 1/31/2012 PCF-Funding Leads to New Bone Scale Index to Measure Remissions in Bone Metastases | Important Tool for Physicians to Use on Patients
• 1/30/2012 Brown Fat Plays Important Role in Weight Management, Prostate Cancer | PCF-funded investigator explores its role
• 1/27/2012 PCF Lays the Foundation for Roswell Park Vaccine Trial
• 1/24/2012 Drug May Slow Early Prostate Cancer: Study | Typically used for an enlarged prostate, it could prevent need for aggressive treatment
• 1/17/2012 New Jersey Leads the Nation in Opposing USPSTF PSA Testing Recommendation | Governor Chris Christie Signs Resolution Passed Unanimously by Legislature
• 1/12/2012 Major Prostate Cancer Gene Mutation Identified | Family history and early diagnosis vital in understanding risk
• 1/5/2012 Energy and Advocacy Preserve Crucial PCa Research Funds
• 1/4/2012 Cancer Incidence, Death Rates Continue to Drop: Report | One million lives saved, largely because of improved prevention, detection and treatment
• 12/20/2011 Making Sense of Cancer Screening Updates | It's important to discuss testing schedule with your doctor
• 12/20/2011 Do Statins Increase Your Risk of Prostate Cancer? | Two research professionals weigh in on the controversial topic
• 12/12/2011 Are Too Many Older People Screened for Cancer? | Debate over testing should weigh health and life expectancy, expert says
• 12/7/2011 Hormone Drugs Might Not Raise Heart-Related Deaths in Prostate Patients | But those with a history of heart disease, stroke may be at higher risk, researchers caution
• 11/15/2011 Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk? | New finding is highly speculative and doesn't demonstrate cause-and-effect, expert says
• 11/3/2011 PCF Funding Leads to MDV3100 Clinical Successes | All trial participants receive drug, not placebo
• 11/3/2011 Radiation Plus Hormone Therapy Extends Life in High-Risk Prostate Cancer | But, surgery might even improve survival more, expert says
• 11/1/2011 Memorial Sloan-Kettering Researchers Discover Prostate Cancer Disease Pathways Regulate Each Other | Researchers discover a specific combination of inhibitors which cause tumor recession in mouse models
• 11/1/2011 AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy | PCF-funded researchers partner with AgonOx Partners and MedImmune to develop tumor-specific agonist
• 10/19/2011 Death by Bureaucracy | Newt Gingrich discusses the USPSTF and their recommendation regarding PSA Testing
• 10/11/2011 Extra Vitamin E May Be Associated With Prostate Cancer | Increase in risk is small, but finding suggests that supplement use can be harmful, researchers say
• 10/10/2011 PCF Responds to U.S. Protective Services Task Force Recommendation on PSA Screening | While needing better guidelines, the PSA still plays an important role in detecting early prostate cancer in informed patients
• 10/7/2011 U.S. Preventive Services Task Force Issues New Recommendation on PSA | PCF to Issue Response on October 10, 2011
• 9/30/2011 Otherwise Healthy Older Men Undertreated for Prostate Cancer| Yet younger men with other serious health issues may be overtreated for the cancer, research shows
• 9/27/2011 U.S. Scientists Map Genome of Advanced Prostate Cancer | Researchers discover genetic 'hypermutations' that help tumors resist common therapies
• 9/26/2011 Couples Counseling Boosts Sex Lives After Prostate Cancer | Both face-to-face and Internet counseling improved erectile dysfunction, love lives, study found
• 9/22/2011 In Older Men, Prostate Biopsies Can Raise Risk of Hospitalization| Experts stress procedure is not benign, strong antibiotics should be given beforehand
• 9/20/2011 New Test Predicts Risk for Impotence After Prostate Cancer Therapy | Series of questions given prior to treatment could help men decide on type of care, researchers say
• 9/20/2011 Genes May Explain Blacks' Bleaker Prostate Cancer Stats | Findings might someday lead to improved treatments for African Americans, researchers say
• 9/19/2011 FDA Expands Approval for Denosumab
• 9/7/2011 Abiraterone (Zytiga) Approved in European Union
• 8/23/2011 FDA to Decide by April 26 on New Xgeva Application| Prevention of metastases represents promising new use for Xgeva
• 8/23/2011 FDA Grants Fast Track Designation to Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone| Decision may make new treatment available for patients faster
• 8/22/2011 5-Gene Signature Identifies Lethal Varieties of Prostate Cancer and May Better Direct Patients to Appropriate Levels of Treatment | Discovery enabled by collaborative effort of scientists at more than a dozen institutes in U.S. and Sweden
• 8/12/2011 Many Men Underestimate Prostate Surgery Side Effects | Incontinence, impotence often worse than anticipated, study finds
• 8/3/2011 New Urine Test Provides Greater Clarity in Diagnosing Prostate Cancer | Detecting Two Cancer-Specific Genetic Fingerprints Can Better Direct Patients and Eliminate Unnecessary Prostate Biopsies
• 7/29/2011 UT Southwestern PCF Young Investigator Identifies New Pathway Explaining Resistance to Prostate Cancer Treatment | Discovery Opens Door to New Target for Drug Development
• 7/28/2011 Abiraterone (Zytiga) Approved in Canada
• 7/27/2011 Intermittent Androgen Deprivation | Changing the standard of care for men with recurrent prostate cancer
• 7/25/2011 Final European Approval of Abiraterone (Zytiga) Expected Within Weeks | Approval will open new treatment option for more than 70,000 patients each year in the EU 
• 7/13/2011 For Some Prostate Cancer Patients, Combo Treatment Improves Survival | For men at 'intermediate risk,' radiation plus 4 months of hormone therapy improves survival, study finds
• 7/6/2011 Stearns' Amendment to Increase Prostate Cancer Research under Department of Defense Gets Bipartisan Approval | $16 Million Increase in Prostate Cancer Research Adopted by Voice Vote
• 6/27/2011 Duke Team Finds New Clues to How Cancer Spreads | PCF-funded investigator lead author of the study
• 6/21/2011 Smoking, Prostate Cancer a Deadly Mix | But risk drops for men who have given up tobacco for 10 years, study finds
• 6/9/2011 Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer | Calling for warning labels, FDA says meds shouldn't be given until other urological conditions are ruled out
• 6/6/2011 News from ASCO: Alpharadin Significantly Improves Overall Survival in Phase III Trial in Patients | Good news for patients with castration-resistant prostate cancer that has spread to the bone
• 6/6/2011 Jury Still Out on Radiation for Early Prostate Cancer | There's too little evidence to say it's superior to 'watchful waiting,' study says
• 5/25/2011 Regular Brisk Walks May Protect Prostate Cancer Patients | Study found those who took them lowered chances of disease progression, death
• 5/23/2011 Half of Prostate Cancers Could Potentially Benefit From New Type of Cancer Drugs | Work was a team effort led by PCF-funded investigator Dr. Arul Chinnaiyan
• 5/18/2011 Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer | This may cut down on unnecessary screening, researchers say
• 5/17/2011 Could Coffee Lower Men's Risk for Prostate Cancer? | In study, drinking 6 or more cups per day was linked to reduced odds for aggressive disease, but more research needed
• 5/17/2011 Surgery Viable for Advanced Prostate Cancer, Study Finds | After removal of their prostate gland, 80% of patients survived 20 years
• 5/16/2011 Smoking Might Raise Odds for Prostate Cancer's Return | Study found that smokers had steeper rise in blood PSA levels, a harbinger of recurrence
• 5/16/2011 PSA Test Could Be Improved to Spot Prostate Cancer | Preliminary studies point to ways to have the screening benefit more men
• 5/16/2011 Prostate Cancer Survival May Be Especially Tough on Gay Men | Post-treatment quality of life scores worse than for heterosexuals, study finds
• 5/4/2011 Aggressive Treatment May Be Beneficial for Early Prostate Cancer | In men under 65, death risk was lower than for those who chose watchful waiting
• 4/28/2011 FDA Aproves Zytiga (abiraterone acetate) for Late-Stage Prostate Cancer | Clinicians will now have a new, powerful, and life-prolonging treatment for advanced prostate cancer patients
• 4/6/2011 KRAS Gene Fusion in Prostate Cancer | Rare gene fusion KRAS represents 25th known type of prostate cancer
• 3/31/2011 Prostate Cancer Screening Doesn't Cut Death Rates: Study | Closer examination of PSA testing continues to underscore both the benefits and shortcomings of the PSA exam and the need for patients to better understand the screening process
• 3/30/2011 Medicare Moves to Pay for Prostate Cancer Drug Provenge | Encouraging news for patients with advanced metastatic disease who may benefit from Provenge treatment
• 3/25/2011 FDA Approves Drug Found to Prolong Lives of Melanoma Patients | Ipilimumab was developed with both melanoma and prostate cancer patients in mind
• 3/24/2011 Short Course of Hormone Therapy Boosts Prostate Cancer Survival | Coupled with radiation, six months of treatment improved odds in locally advanced cases, researchers found
• 3/24/2011 Prostate Cancer Spreads to Bones by Overtaking the Home of Blood Stem Cells | Pathway could be targeted by new drugs to stop bone metastatses before they take root
• 3/7/2011 UCLA Researchers Use 'Nano-Velcro' Technology to Improve Capture of Circulating Cancer Cells | New method may help improve diagnosis and treatment-monitoring of cancer
• 3/2/2011 Scientists Target Aggressive Prostate Cancer | SPINK1 gene could be to prostate cancer what HER2 has become for breast cancer
• 2/24/2011 Rapid Rise in PSA Levels a Poor Predictor of Prostate Cancer | Measuring changes over time leads to unnecessary biopsies, researchers say
• 2/24/2011 PSA Screening for Prostate Cancer Dips in Large U.S. Health Network | Follows 2008 guidelines reporting that aggressive PSA screening had led to harm from unnecessary treatment
• 2/23/2011 Newer Drug May Help Prevent Fracture in Men With Prostate Cancer | Slightly fewer patients on denosumab experienced 'skeletal events' than those on Zometa, study found
• 2/15/2011 Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? | Researchers say these men may turn out to be candidates for screening, but more study needed
• 2/15/2011 PSA Test Cut-off Could Signal Low-Risk Prostate Cancer | Another study suggests drug for enlarged prostate might also curb tumor progression
• 2/9/2011 First Look at Prostate Cancer Genome Yields Insights | Newly detected DNA changes may eventually lead to better treatments
• 2/3/2011 New Gene Test May Identify Aggressive Prostate Cancers | Info would help doctors match patients with best treatment option
• 1/5/2011 Exercise May Improve Odds Against Prostate Cancer Death | Three hours or more of vigorous activity a week upped patients' long-term survival
• 1/4/2011 PCF Investment in Circulating Tumor Cells Delivers $30 Million Investment by Johnson & Johnson within Three Years | The new partnership will hopefully make the CTC technology easier and more affordable to use